On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.38 SEK | +0.37% |
|
-6.60% | -29.77% |
Jun. 19 | Ziccum Signs Evaluation Agreement with Recode Therapeutics for LaminarPace mRNA Study | CI |
Apr. 29 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-29.77% | 7.81M | |
+3.84% | 97.02B | |
+4.74% | 40.94B | |
-11.48% | 33.35B | |
+81.75% | 29.53B | |
-13.94% | 15.76B | |
-3.33% | 13.65B | |
-12.64% | 11.44B | |
+166.50% | 10.08B | |
+4.79% | 9.06B |